|
|||||||
|
Gout is a form of arthritis that is caused by an excess of uric acid in the bloodstream. This causes crystals to form in the joints, typically in the big toe. Results of a recent research project, carried out by the University of Pittsburgh School of Medicine and published in the Archives of Internal [...] Interesting story from New Zealand discussing the possibility that high rates of gout in Pacific Islanders may be a genetic trait passed to them by ancient voyagers across the Pacific Ocean. Dr. Hallie Buckley, from Otago University’s Department of Anatomy and Structural Biology, has been studying bones from the oldest cemetery found in thePacific [...] Arthritis Awareness Week is March 29th to April 4th, an initiative of Arthritis Australia, and is a time of promotional and educational activities, held around the country, to raise awareness about arthritis, its effects, and the various treatment and management options available. Arthritis Australia hopes that these activities will make all Australians aware that [...] Gout has typically been treated with non-steroidal anti-inflammatory drugs (NSAIDs). But a report presented at the American College of Rheumatology on October 30, 2007 indicates that a new therapy may provide greater relief than NSAIDs. The research was a trial involving 10 patients with chronic, active, gouty arthritis. They averaged 62 years of age [...] Gout is a painful condition which results from high levels of uric acid in the blood. Over time the uric acid forms crystals in the joints which leads to inflammation, stiffness and pain. Normally, the kidneys remove uric acid from the blood and eliminate it in urine. But the kidneys in those with gout [...] Gout is a painful condition resulting from a buildup of urate crystals in joints, most often in the toes. Urate crystals develop due to elevated uric acid levels in the blood and are generally attributed to high levels of sugar intake. A recent study published in the April 2008 Archives of Neurology concludes that [...] Gout results from elevated levels of uric acid in the blood. Researchers at Duke University Medical Center and Savient Pharmaceuticals have recently conducted a phase II trial of a drug called pegloticase which shows great promise in reducing the level of uric acid in the blood to targets levels within a few hours. [...] |
  
|
||||||
|
Copyright © 2012 Current Arthritis News and Research - All Rights Reserved
|
|||||||
